Candela Picoway resolve
The new approach to building new collagen and elastin in the treatments acne scars and wrinkles.
In brief, 15- to 20-minute treatment sessions, the PicoWay Resolve system transforms skin while leaving the epidermis intact. So patients can get back to their lives quickly, without significant side effects.
Minimise risk in patients with darker skin shades.
The candela PicoWay system’s ultra-short picosecond pulses are 100 times shorter than Q-switch lasers. in the trillionths of a second. Picosecond pulses will minimise the risk of side effects and thermal damage.
Side effects such as hyperpigmentation and scarring can be a thing of the past with Candela Picoway laser.
Candela Picoway
The complete picosecond laser
The PicoWay system features three wavelengths (1064nm, 785nm, and 532nm) and multiple handpieces to maximise your treatment options — and your ROI.
- Improve and remove scarring and wrinkles
- Address a wide range of beingh pigments
- Treat a wide range of tattoos including difficult colours such as green
key benefits of Candela picoway
With the Candela picoway you have the opportunity to achieve fantastic results for your patients and for your business.
4 reasons your patients will love it
clinically proven to deliver
- Reduce Acne scarring after just 3 treatment
- Improvement of wrinkles and severity
- high rate pigmented clearance
- emove of multi-coloured tattoos
Photoacoustic effect.
Ultra-short pulses enable the strong photoacoustic impact needed to effectively fracture pigment particles without overheating surrounding skin tissues.
System
- The Candela PicoWay flexible treatment parameters put you in control of
- wavelength,
- fluence,
- repetition rate
- spot size
- for highly customizable treatments.
- Plus, with the shortest picosecond pulses, the PicoWay system’s skin treatment pallet extends from the lightest to even the darkest skin types
- Three true picosecond wavelengths for optimal treatment customization.
- PicoWay system: 1064nm, 785nm, 532nm
There are no reviews yet.